The cancer types where TP53 is overexpressed include (1) Bladder Urothelial Carcinoma (BLCA), (2) Breast Invasive Carcinoma (BRCA), (3) Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (CESC), (4) Colon Adenocarcinoma (COAD), (5) Diffuse Large B-cell Lymphoma (DLBC), (6) Esophageal Carcinoma (ESCA), (7) Glioblastoma Multiforme (GBM), (8) Head and Neck Squamous Cell Carcinoma (HNSC), (9) Kidney Renal Clear Cell Carcinoma (KIRC), (10) Kidney Renal Papillary Cell Carcinoma (KIRP), (11) Liver Hepatocellular Carcinoma (LIHC), and (12) Lung Adenocarcinoma (LUAD). This evidence concerns the gene TP53 and cervical squamous cell carcinoma.